Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7EP6

Engineered Hepatitis B virus core antigen T=4

7EP6 の概要
エントリーDOI10.2210/pdb7ep6/pdb
EMDBエントリー31234
分子名称Capsid protein,Immunoglobulin G-binding protein A (1 entity in total)
機能のキーワードcancer therapy, epidermal growth factor receptor 1, affibody, virus like particle
由来する生物種Hepatitis B virus genotype C subtype adr (strain Japan/adr4/1983) (HBV-C)
詳細
タンパク質・核酸の鎖数4
化学式量合計147212.31
構造登録者
Jeong, H.,Heo, Y.,Yoo, Y.,Ryu, B.,Yun, J.,Cho, H.,Lee, W. (登録日: 2021-04-26, 公開日: 2021-09-01, 最終更新日: 2024-10-09)
主引用文献Heo, Y.,Jeong, H.,Yoo, Y.,Yun, J.H.,Ryu, B.,Cha, Y.J.,Lee, B.R.,Jeon, Y.E.,Kim, J.,Jeong, S.,Jo, E.,Woo, J.S.,Lee, J.,Cho, H.S.,Lee, W.
Structural and Functional Characterizations of Cancer Targeting Nanoparticles Based on Hepatitis B Virus Capsid.
Int J Mol Sci, 22:-, 2021
Cited by
PubMed Abstract: Cancer targeting nanoparticles have been extensively studied, but stable and applicable agents have yet to be developed. Here, we report stable nanoparticles based on hepatitis B core antigen (HBcAg) for cancer therapy. HBcAg monomers assemble into spherical capsids of 180 or 240 subunits. HBcAg was engineered to present an affibody for binding to human epidermal growth factor receptor 1 (EGFR) and to present histidine and tyrosine tags for binding to gold ions. The HBcAg engineered to present affibody and tags (HAF) bound specifically to EGFR and exterminated the EGFR-overexpressing adenocarcinomas under alternating magnetic field (AMF) after binding with gold ions. Using cryogenic electron microscopy (cryo-EM), we obtained the molecular structures of recombinant HAF and found that the overall structure of HAF was the same as that of HBcAg, except with the affibody on the spike. Therefore, HAF is viable for cancer therapy with the advantage of maintaining a stable capsid form. If the affibody in HAF is replaced with a specific sequence to bind to another targetable disease protein, the nanoparticles can be used for drug development over a wide spectrum.
PubMed: 34502049
DOI: 10.3390/ijms22179140
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.86 Å)
構造検証レポート
Validation report summary of 7ep6
検証レポート(詳細版)ダウンロードをダウンロード

227344

件を2024-11-13に公開中

PDB statisticsPDBj update infoContact PDBjnumon